Ranking deep dive · September 2026. Educational content—not medical advice.
Disclosure: We may have a financial affiliation with entities here. Rankings are editorial; see our methodology.
Wave 1 heavily weighted Trustpilot and Google, then tested reviews against clinician access, pharmacy structure, labs, follow-up, pricing, state honesty, and marketing restraint. A score cannot establish licensure, pharmacy transparency, or a live peptide menu. Google remains TBD where no stable independent profile was available; widgets are company claims, not audited ratings. Sample size matters: 4.9 across ~36K–39K reviews is denser evidence than a similar score across ~900.
Beyond reviews
We ask whether there is a patient-specific prescription, licensed clinician, ongoing access, named 503A/503B pharmacy, labs, follow-up, clear pricing/state exclusions, and restrained language. Reviews cannot turn marketing into verified evidence. Compounded medications are not FDA-approved; many wellness peptides remain investigational or unapproved.
Why Ivím is #1
Ivím combines 4.9/5 across ~36K–39K Trustpilot reviews in September 2026 snapshots with physician-led infrastructure and a peptide waitlist. Honest rollout labeling plus dense review evidence produced the top composite result. #1 is a methodology outcome, not a guarantee, availability claim, or medical recommendation.
What can change
Reviews, live menus, pharmacy evidence, state access, pricing, labs, and follow-up can change rankings. PCAC recommendation ≠ FDA approval; Category 2 removal ≠ Category 1 permission.
Medical disclaimer: Educational content, not medical advice, diagnosis, or treatment. Consult a licensed clinician.